OKYO Pharma Limited

NasdaqCM:OKYO Stock Report

Market Cap: US$82.4m

OKYO Pharma Future Growth

Future criteria checks 0/6

OKYO Pharma's earnings are forecast to decline at 16.3% per annum while its annual revenue is expected to grow at 64.2% per year. EPS is expected to decline by 11.3% per annum.

Key information

-16.3%

Earnings growth rate

-11.30%

EPS growth rate

Biotechs earnings growth25.2%
Revenue growth rate64.2%
Future return on equityn/a
Analyst coverage

Low

Last updated01 May 2026

Recent future growth updates

Recent updates

Analysis Article • Jan 11

OKYO Pharma Limited (NASDAQ:OKYO) Shares Could Be 40% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for OKYO Pharma is US$4.58 based on 2 Stage Free Cash Flow to Equity Current...

Earnings and Revenue Growth Forecasts

NasdaqCM:OKYO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202940-58-21-422
3/31/20286-62-31-472
3/31/2027N/A-18-13-122
3/31/2026N/A-13-11-63
9/30/2025N/A-5-3-3N/A
6/30/2025N/A-5-2-2N/A
3/31/2025N/A-5-2-2N/A
12/31/2024N/A-8-2-2N/A
9/30/2024N/A-11-3-3N/A
6/30/2024N/A-14-6-6N/A
3/31/2024N/A-17-9-9N/A
12/31/2023N/A-17-10-10N/A
9/30/2023N/A-17-11-11N/A
6/30/2023N/A-15-9-9N/A
3/31/2023N/A-13-8-8N/A
12/31/2022N/A-11-7-7N/A
9/30/2022N/A-7-5-5N/A
6/30/2022N/A-6-5-5N/A
3/31/2022N/A-5-5-5N/A
12/31/2021N/A-5-5-5N/A
9/30/2021N/A-5-4-4N/A
6/30/2021N/A-4-3-3N/A
3/31/2021N/A-3-2-2N/A
12/31/2020N/A-2-1-1N/A
9/30/2020N/A0-1-1N/A
6/30/2020N/A-1-1-1N/A
3/31/2020N/A-2-1-1N/A
12/31/2019N/A-3N/AN/AN/A
9/30/2019N/A-5-2-2N/A
6/30/2019N/A-5N/A-2N/A
3/31/2019N/A-5N/A-2N/A
12/31/2018N/A-4N/AN/AN/A
9/30/2018N/A-3N/A-2N/A
6/30/2018N/A-15N/A-2N/A
3/31/2018N/A-28N/A-2N/A
12/31/2017N/A-27N/A-1N/A
9/30/2017N/A-26N/A-1N/A
6/30/2017N/A-13N/A-1N/A
3/31/2017N/A0N/A-1N/A
12/31/2016N/A0N/A0N/A
9/30/2016N/A-1N/A0N/A
6/30/2016N/A-1N/A0N/A
3/31/2016N/A-1N/A-1N/A
9/30/2015N/A-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OKYO is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OKYO is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OKYO is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OKYO is forecast to have no revenue next year.

High Growth Revenue: OKYO is forecast to have no revenue next year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if OKYO's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/18 12:55
End of Day Share Price 2026/05/15 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OKYO Pharma Limited is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yi ChenH.C. Wainwright & Co.
Elemer PirosLucid Capital Markets
Biren AminPiper Sandler Companies